What Impact Has COVID-19 Had on Doing Healthcare Deals?
The evolving European healthcare market continues to drive investment activity to record levels, however is the timing of deals being impacted by the pandemic? McDermott's panel of industry experts will address a range of issues facing healthcare investors, exploring key considerations for the savvy investor in today's market including:
Have prices been impacted for healthcare assets?
How do investment strategies differ by health sub-sector?
Is a one-off impact with a V-shaped recovery expected following the pandemic?
What regulatory impact or changes are expected as a result of COVID-19 and how will these changes affect the deal landscape?
This fast-paced and collaborative series is exclusively available for senior leaders and investors in the global healthcare services industry.